decisionhealth Newsletters, Answer Books - 2009 Issue 10 (October)
Opioid Management / Patterns that may lead to a DEA case against providers
Subscribe or sign in to view the full article.
Article Overview
This short article is a high-level overview of DEA-identified patterns that may be relevant in opioid and controlled-substance management reviews. It is intended for clinicians, coders, compliance staff, and auditors who want to understand the general kinds of prescribing behaviors discussed in enforcement-related guidance, without providing coding instructions or clinical decision support.
Why This Topic Matters
The topic is relevant to compliance monitoring, controlled-substance oversight, and provider risk management. It helps readers understand the broad enforcement concerns that can arise in opioid prescribing reviews.
What You Will Learn
- The general categories of prescribing behaviors that may attract regulatory attention
- How DEA enforcement-related guidance is framed at a high level
- Why controlled-substance prescribing patterns can matter in compliance reviews
- The kinds of issues compliance teams may look for in provider oversight
Who Should Read This
- Physicians
- Compliance officers
- Medical coders
- Auditors
- Practice managers
- Risk management staff
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com